Reference | </br>1:Evaluation of the effects on choroidal thickness of bimatoprost 0.03% versus a brinzolamide 1.0%/timolol maleate 0.5% fixed combination. Akyol N, Kalkisim A, Turk A, Kola M, Imamoglu HI.Cutan Ocul Toxicol. 2017 Apr 25:1-7. doi: 10.1080/15569527.2017.1315128. [Epub ahead of print] PMID: 28376651 </br>2:Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients. Aihara M, Adachi M, Matsuo H, Togano T, Fukuchi T, Sasaki N; JAC Study group†..Acta Ophthalmol. 2017 Apr 3. doi: 10.1111/aos.13401. [Epub ahead of print] PMID: 28371482 </br>3:The 24-Hour Effects of Brinzolamide/Brimonidine Fixed Combination and Timolol on Intraocular Pressure and Ocular Perfusion Pressure. Seibold LK, DeWitt PE, Kroehl ME, Kahook MY.J Ocul Pharmacol Ther. 2017 Apr;33(3):161-169. doi: 10.1089/jop.2016.0141. Epub 2017 Jan 27. PMID: 28129020 </br>4:Effect of prophylactic intraocular pressure-lowering medication (brinzolamide) on intraocular pressure after ranibizumab intravitreal injection: A case-control study. Song S, Yu XB, Dai H.Indian J Ophthalmol. 2016 Oct;64(10):762-766. doi: 10.4103/0301-4738.195006. PMID: 27905340 Free PMC Article</br>5:Comparison of dorzolamide/timolol vs brinzolamide/brimonidine fixed combination therapy in the management of primary open-angle glaucoma. Kozobolis V, Panos GD, Konstantinidis A, Labiris G.Eur J Ophthalmol. 2017 Mar 10;27(2):160-163. doi: 10.5301/ejo.5000826. Epub 2016 Jul 16. PMID: 27445072 </br>6:Effects of Brinzolamide, a Topical Carbonic Anhydrase Inhibitor, on Corneal Endothelial Cells. Nakano T, Inoue R, Kimura T, Suzumura H, Tanino T, Yamazaki Y, Yoshikawa K, Tatemichi M.Adv Ther. 2016 Aug;33(8):1452-9. doi: 10.1007/s12325-016-0373-y. Epub 2016 Jul 6. PMID: 27384190 </br>7:Ocular hypotensive effect of fixed-combination brinzolamide/brimonidine adjunctive to a prostaglandin analog: a randomized clinical trial. Fechtner RD, Myers JS, Hubatsch DA, Budenz DL, DuBiner HB.Eye (Lond). 2016 Oct;30(10):1343-1350. doi: 10.1038/eye.2016.126. Epub 2016 Jul 1. PMID: 27367743 Free PMC Article</br>8:Crystal structure of Brinzolamide: a carbonic anhydrase inhibitor. Zheng H, Lou B.Acta Crystallogr E Crystallogr Commun. 2016 Apr 15;72(Pt 5):692-5. doi: 10.1107/S2056989016006022. eCollection 2016 May 1. PMID: 27308020 Free PMC Article</br>9:In vitro and in vivo corneal effects of latanoprost combined with brimonidine, timolol, dorzolamide, or brinzolamide. Fukuda M, Takeda N, Shibata S, Shibata N, Shibata T, Sugiyama K, Sasaki H.Eur J Pharmacol. 2016 Sep 15;787:43-6. doi: 10.1016/j.ejphar.2016.05.012. Epub 2016 May 12. PMID: 27181069 </br>10:Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs. Lo JS, Pang PM, Lo SC.Clin Ophthalmol. 2016 Mar 31;10:583-6. doi: 10.2147/OPTH.S98607. eCollection 2016. PMID: 27099466 Free PMC Article
|